1. 羅李烟(2003)。文旦果酒之釀造,花蓮區農業改良場第四十五期。
2. 施宏哲、劉生明、徐志誠、張光雄(1997)。四君子湯抗胃潰瘍作用之研究。明通醫藥。217:15-16。3. 周文進編著(2003)。釀酒技術與評酒實務,科技圖書公司。
4. 高毓翎(2003)。以焙烤方式製造龍眼香甜酒之研究,國立台灣大學食品科技研究所碩士論文。5. 東海大學景觀學系賴明洲(2000)。檄樹聖果─諾尼(Noni), 林業研究專訊第36期-2000/06出版。
6. 廖隆德(2001)。蘭嶼藥用植物資源之調查研究。中國醫藥學院中國藥學研究所碩士論文。7. 張慧敏(2002)A。“神奇的諾麗”。生智出版社。台灣。
8. 張慧敏(2002)B。“諾麗我的元氣健美秘方”。生智出版社。台灣。
9. 林靜宜(2000)。巴斯德殺菌芒果汁求最適溫度與時間之探討,國立屏東科技大學食品系碩士論文。10. 鍾玉玲(2003)。海巴戟天葉、莖及果實粗萃取物的抗氧化活性之比較。嘉南藥理科技大學生物科技研究所。11. 汪群超(2003)。破布子。國立屏東科技大學食品科學系碩士班碩士學位論文。屏東,台灣。12. 陳雅惠(2002)。龍鬚菜果膠酯所催化轉醯基反應之探討。國立屏東科技大學食品科學系碩士班碩士學位論文。屏東,台灣。13. 陳正賢(2002)。發酵李子酒製程之研究。輔仁大學食品營養系碩士論文。14. 李建興(2003)。龍眼蜂蜜甜酒及蒸餾酒之研發。大葉大學食品工程學系碩士論文。15. 廖隆德(2001)。蘭嶼藥用植物資源之調查研究。中國醫藥學院中國藥學研究所碩士論文。
16. 唐靜宜(2003)。乳酸發酵綜合蔬果汁之試製及儲藏期間成分變化與品質特性之探討。國立中興大學食品科學系碩士論文。17. 尤淑芬(2004)。洋蔥醋發酵之菌種篩選暨發酵方法之研究。國立中興大學。食品科學系碩士論文。18. 王麗蓉(2004)。製麴與酒母製備條件對清酒釀造之影響。國立中興大學食品科學系碩士論文。19. 呂丹妮、陳安德、張玉冬、曾哲明(1995)。補氣健脾藥四君子湯調節人體B 淋巴球免疫分泌A型免疫球蛋白。師大生物學報。30 (2):83-95。20. 梁佑慎(2004)。市售新鮮蔬果抗氧化力之研究,國立屏東科技大學 熱帶農業暨國際合作研究所碩士論文。
21. 洪英豪(2005)。蜈蚣藻乳酸發酵液之抗氧化性探討,國立臺灣海洋大學食品科學系碩士學位論文。22. 蔡漢霓(2004)。巴西蘑菇萃取物抗氧化活性之研究,國立成功大學醫學檢驗生物技術研究所碩士論文。23. 康淑敏(2004)。辣木組成分與生理活性之探討,國立台灣海洋大學食品科學系碩士學位論文。24. 黃煜、葉嘉新(1998)。自由基與抗氧化物在心臟血管疾病所扮演的角色。中化藥訊。38:18-27。25. 蔡坤志(2002)。自由基簡介與其臨床應用。臨床醫學49:123-129。
26. 楊淑娟(2005)。Noni 果汁抗氧化性、ACE 抑制活性和其純化物質Scopoletin 及衍生物之化學結構鑑定,東海大學食品科學研究所碩士學位論文。27. 姜淑繡(2001)。省產蘿蔔之抗氧化性研究。大葉大學食品工程研究所碩士論文。28. 陳冠良(2005)。大豆屬一條根異黃酮類化合物含量與抗氧化性之鑑定。國立台灣海洋大學食品科學系碩士學位論文。
29. 鄭秀粧(2004)。乳酸菌於黑豆奶、還原奶中成長情形及貯藏期間變化。國立中興大學食品科學系碩士論文30. 中國國家標準全文資料庫線上檢索系統(2007)。
31. 吳其芸(2001)。運動對於人體血液中脂質過氧化及抗氧化物含量之影響。台北醫學院公共衛生學研究所碩士論文。32. A.G. GOPALA KRISHNA R. BABYLATHA (1989). Oil Technol. Assox. (India),Department of Lipid Science & Traditional Foods Central Food Technological Research Institute Mysore-570020 India 21, 26-27.
33. John A. (1960),An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) with antitumour activity. Department of Pharmacology,Burns School of Medicine,East West Road,University of Hawaii,Honolulu,HI 96822,USA.
34. author unlisted ted. 2001,”Noni plant may help TB "AIDS Patient Care STDS” Mar;15(3):175.
35. Bartosz, G. (2003) Generation of reactive oxygen species in biological systems. Comments Toxicol. 9:5-21.
36. Best R. J. (1944) Studies on a fluorescent substance present in plants. 2. Isolation of the substance in a pure state and its identification as 6-methoxy-7-hydroxy 1: 2 benzo-pyrone. Austral. J. Expt. Biol. Med. Sci.22: 251-255.
37. Bushnell, O. A., Fukuda, M. and Makinodan, T. (1950) The antibacterial properties of some plants found in Hawaii. Pac. Sci. 4: 167-183
38. Cancer preventive effect of Morinda citrifolia (Noni). Ann N Y Acad Sci. 2001 Dec;952:161-8.
39. Cancer Res( 2001) Aug 1;61(15):5749-56
40. Duncan S. H., Flint, H. J. and Stewart, C. S. (1998) Inhibitory activity of gut bacteria against Escherichia coli O157 mediated by dietary plant metabolites. FEMS Micro. Biol. Lett. 164: 283-288.
41. Fang, Y. Z., S. Yang, and G. Wu (2002) Free radicals, antioxidants, and nutrition. Nutrition 18:872-879.
42. Green, M. J. and A. O. Hill. (1984).Methods in Enzymology 105: 3-22.
43. Halliwell, B. (1994) Free radicals and antioxidants: a personal view. Nutr.Rev.52(8):253-265.
44. Halliwell, B. and Gutteridge John M. C.(1984)Oxygentoxicity,oxygenradicals, transition metals and disease. Biochem. J. 219:1
45. Heinicke, R. M. (1983) Xeronine, an alkaloid, useful in medical, food and industrial fields. US 4409144.
46. Heinicke,R.M . (1985)"The Pharmacologically Active Ingredient of Noni." Pacific Tropical Botanical Garden.15(1):10-4.
47. Hiramatsu,T.etal.(1993)"Induction Normal Phenotypes in RAS-transformed Cells by Damnacanthal from Morinda." Cancer Letters. 73:161-6
48. Hirazumi A, Furusawa E, Chou SC, et al. 1994。Anticancer activity of Morinda citrifolia (noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Proc West Pharmacol Soc.;37:145–146.
49. Hirazumi A, Furusawa E. (1999)An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phytother Res. Aug;13(5):380-7.
50. Hirazumi, A. et al. (1994)"Anticancer Activity of Morinda Citrifolia on Intraperitoneally Implanted Lewis Lung Carcinoma in Syngenic Mice."Proc.West Pharmacol. Soc.37:145-6
51. Hiwasa T, Arase Y, Chen Z, Kita K, Umezawa K, Ito H, et al.(1999)Stimulation of ultraviolet-induced apoptos is of human fibroblast UVr-1 cells by tyrosine kinas e inhibitors. FEBS Lett; 444: 173-6.
52. http://Nonispa.com/Nonisec.html
53. http://www.ctahr.hawaii.edu/Noni/fruit_juices.asp
54. http://www.Nonis.com.tw/Nonis2/Nonis2.htm
55. http://www.tdais.gov.tw/
56. Imark, C., K. Markus, and B. Stefan (2001) Occurrence and activity of natural antioxidants in herbal spirits. Innov. Food Sci. Emerg. Technol.1: 239-243.
57. Jacob, R. A.( 1995). The integrate antioxidant system. Nutr Res. 15(5):755-766.
58. Jhoo, Jin-Woo; Sang, Shengmin; He, Kan; Cheng, Xiaofang; Zhu, Nanqun; Stark, Ruth E.;Zheng, Qun Yi; Rosen, Robert T.; Ho, Chi-Tang(2001). “Characterization of the Triterpene Saponins of the Roots and Rhizomes of Blue Cohosh (Caulophyllum Thalictroides)”. J. Agric. Food Chem. 49,5969-5974.
59. Kinsella, J., B. Lokesh, and R. Stone (1990) Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am. J. Clinical Nutr. 52: 1-28.
60. Kuo, J. M., D. B. Yen, and B. S. Pan. (1999). Rapid photometric assay evaluating antioxidative activity in edible plant material.Journal of Agricultural and Food Chemistry 47: 3206-3209.
61. Lacaille-Dubois, M. A., Franck, U. and Wagner, H. (2001) Search for potential Angiotensin Converting Enzyme (ACE)-inhibitors from plants.Phytomedicine 8(1): 47-52.
62. Levand, O. and Larson, H. O. (1979) Some chemical constituents of Morinda citrifolia. Planta Med. 36: 186-187.
63. Liu G. Bode A. Ma WY. Sang S. Ho CT. and Dong Z. (2001)Two novel glycosides from the fruits of Morinda citrifolia (Noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Research. 61(15):5749-56, .
64. Moskovitz, J., M. B. Yim, and P. B. Chock (2002) Free radicals and disease.Arch. Biochem. Biophys. 397(2): 354-359.
65. Mueller BA, Scott MK, Sowinski KM, and Prag KA.(2000) Noni juice (Morinda citrifolia): hidden potential for hyperkalemia? Am J Kidney Dis. Feb;35(2):310-2.
66. Novel glycosides from Noni (Morinda citrifolia). J Nat Prod. (2000) Aug;63(8):1182-3.
67. Rikans, L. E., and K. R. Hornbrook (1997) Lipid peroxidation, antioxidant protection and aging. Biochem. Biophys. Acta. 1362: 116-127.
68. Sang, S., Cheng, X., Zhu, N., Stark, R. E., Badmaev, V., Ghai, G., Rosen, R. T.and Ho, C. T. (2001) Flavonol glycosides and novel iridoid glycoside from the leaves of Morinda citrifolia. J. Agric. Food Chem. 49 (9): 4478-4481.
69. Sang, S.; Cheng, X.; Zhu, N.; Wang, M.; Jhoo, J.W.; Stark, Ruth E.; Badmaev, V.; Ghai, G.;Rosen, R.T.; and Ho, C.-T(2001). Iridoid Glycosides from the Leaves of Morinda citrifolia. Journal of Natural Products, 64, 799-800.
70. Shimada, K., Fujikawa, K., Yahara, K. and Nakamura, T. (1992) Antioxidativ eproperties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. J. Agric. Food Chem. 40: 945-948.
71. Solomon,N.,Passwater,R."The Birth of Noni."The Experts'Optimal Health Journal. http://www.noniland.nl/default_big5-7.htm
72. Su, B. N., Pawlus, A. D., Jung, H. A., Keller, W. J., McLaughlin, J. L. and Kinghorn, A. D. (2005) Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. J. Nat. Prod. 68:592-595.
73. Su, C. X., Jensen, J. C., and Zhou, B. N. (2005) Morinda citrifolia (Noni): Its effect on insulin secretion by G-protein-coupled receptor systems. 229th ACE National Meeting, March 13-17.
74. Tetrahedron Lett. (2001), 42, 1823-1825.
75. Two novel glycosides from the fruits of Morinda citrifolia (Noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.Cancer Res. 2001 Aug 1;61(15):5749-56.
76. Umezawa K(1992). Isolation of 1-methoxy-2-foremyl-3-hydroxyanthraquinone from M citrifolia and neoplasm inhibitors containing the same. Japan Kokai Tokyo Koho JP 06 87,736 (94-87,736) Appl 1992; 92/264, 311 07.
77. Wang M, Kikuzaki H, Csiszar K, Boyd CD, Maunakea A, Fong SF, Ghai G, Rosen RT, Nakatani N, and Ho CT. (1999) Novel trisaccharide fatty acid ester identified from the fruits of Morinda citrifolia (Noni). J Agric Food Chem. Dec;47(12):4880-2.
78. Wang Mian-Ying et al(2002)。,Morinda citrifolia (Noni): A literature review and recent advances in Noni research1 Wang MY et a l / Acta Pharmacol Sin Dec; 23 (1 2): 1127 -1141
79. Yamaguchi, S., Ohnishi, J., Sogawa, M., Maru, I., Ohta, Y. and Tsukada, Y.(2002) Inhibition of Angiotensin I converting enzyme by Noni (Morinda citrifolia) juice. Nippon Shokuhin Kagaku Kogaku Kaishi 49(9): 624-627.
80. Yasuaki Tatsumi, Yong-Yeon Cho, Zhiwei He, Hideya Mizuno, Hong Seok Choi, Ann M. Bode and Zigang Dong (1990)Involvement of the Paxillin Pathway in JB6 Cl41 Cell Transformation, Hormel Institute, University of Minnesota, 801 16th Avenue Northeast, Austin, MN 55912.
81. Younos, C.et al. (1990) "Analgesic and Behavioral Effects of Morinda Citrifolia." Planta Medica.56:430-4
82. Yu, H., Li, S., Huang, M. T. and Ho, C. T. (2004) Anti-inflammatory constituents in Noni (Morinda citrifolia) fruits. IFT Annual Meeting 33F-28, July 12-16 Las Vegas, NV.
83. Zin, Z. M., Abdul-Hamid, A. and Osman, A. (2002) Antioxidative activity of extracts from Mengkudu (Morinda citrifolia L.) root, fruit and leaf. Food Chem. 78: 227-231.